1. Hong Kong Stocks

  2. •

    Industrials

  3. •

    Engineering & Construction
Ju Fu Tang Biotech Holdings Co., Ltd

Ju Fu Tang Biotech Holdings Co., Ltd

8217.HK
Ju Fu Tang Biotech Holdings Co., LtdHK flagHong Kong Stock Exchange
0.12
HKD
- -
- -
35.02MMarket Cap

Total Valuation

Ju Fu Tang Biotech Holdings Co., Ltd carries a market capitalization of 35.02M, placing it among publicly traded companies globally. Its enterprise value stands at 29.08M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap35.02M
Enterprise Value29.08M

Share Statistics

Ju Fu Tang Biotech Holdings Co., Ltd currently has 301.86M shares outstanding.

Shares Outstanding301.86M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.48, and the price-to-book ratio stands at -0.84.

PE RatioN/A
PS Ratio0.48
PB Ratio-0.84
P/TBV Ratio1.37
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Ju Fu Tang Biotech Holdings Co., Ltd trades at an EV/EBITDA multiple of 13.91 and an EV/FCF ratio of 80.77. The EV/Sales ratio of 0.33 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 13.91 provides insight into valuation relative to core operating earnings.

EV / Sales0.33
EV / EBITDA13.91
EV / EBIT13.91
EV / FCF80.77

Financial Position

Ju Fu Tang Biotech Holdings Co., Ltd maintains a current ratio of 1.49, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 38.81, indicating elevated leverage, while an interest coverage ratio of -0.05 demonstrates limited ability to service its debt obligations.

Current Ratio1.49
Quick Ratio0.41
Debt / Equity38.81
Debt / EBITDA-666.67
Interest Coverage-0.05

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-26.96
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)-1,826.06
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Stock Price Statistics

Ju Fu Tang Biotech Holdings Co., Ltd's stock has declined approximately -63.1746% over the past 52 weeks. The 50-day moving average sits at 0.19, while the 200-day moving average is 0.29.

Beta (5Y)N/A
52-Week Price Change-63.1746%
50-Day Moving Average0.19
200-Day Moving Average0.29
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Ju Fu Tang Biotech Holdings Co., Ltd generated 87.35M in revenue and converted that into -29.23M in net income, yielding earnings per share of -0.10. EBITDA reached -18,000.00, while operating income came in at -18,000.00.

Revenue87.35M
Gross Profit1.85M
Operating Income-18,000.00
Pretax Income-29.23M
Net Income-29.23M
EBITDA-18,000.00
EBIT-18,000.00
Earnings Per Share (EPS)-0.10

Balance Sheet

Ju Fu Tang Biotech Holdings Co., Ltd holds 25.19M in cash and equivalents against 12.00M in total debt, resulting in a net debt position of 10.03M. Total book value stands at -50.03M, with working capital of 30.64M providing operational flexibility.

Cash & Cash Equivalents25.19M
Total Debt12.00M
Net Debt10.03M
Equity (Book Value)-50.03M
Book Value Per Share-0.17
Working Capital30.64M

Margins

Ju Fu Tang Biotech Holdings Co., Ltd operates with a gross margin of 2.12, reflecting its pricing power and cost economics. The operating margin of -0.02 and net profit margin of -33.46 provide insight into operational efficiency.

Gross Margin2.12
Operating Margin-0.02
Pretax Margin-33.46
Profit Margin-33.46
EBITDA Margin-0.02

Stock Splits

Ju Fu Tang Biotech Holdings Co., Ltd's most recent stock split took place on September 13, 2021 with a 4:1 split ratio.

Last Split Date9/13/2021
Split Ratio4:1

Scores

Ju Fu Tang Biotech Holdings Co., Ltd posts an Altman Z-Score of 0.26, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score0.26